AstraZeneca (AZN) Income Statement: Revenue & Earnings

AstraZeneca Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scale:

Scroll to see more

AstraZeneca PLC income statement - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	58.74	52.94	45.81	44.35	37.11	29.27	24.50	20.99	23.45
Cost of Revenue	10.63	13.25	8.27	12.39	14.51	7.61	6.77	5.92	6.07
Gross Profit	48.11	39.70	37.54	31.96	22.60	21.66	17.73	15.06	17.38
Operating Expenses
Research & Development	14.23	11.96	10.94	9.76	8.38	6.46	5.35	5.00	5.65
Selling, General & Administrative	20.51	15.21	19.76	17.98	11.36	10.24	9.56	8.32	8.11
Operating Expenses	34.36	27.18	29.35	27.45	19.79	16.69	14.91	13.32	13.76
Operating Income	13.74	12.52	8.19	4.51	2.81	4.97	2.82	1.74	3.62
Other Income/Expense
Interest Income	0.36	0.33	0.33	0.08	0.01	0.04	0.12	0.09	0.07
Interest Expense	1.69	1.36	-1.22	1.33	0.76	0.78	0.78	0.70	0.69
Other Income/Expense	-1.34	-4.01	-1.29	-1.26	-3.07	-0.82	-1.26	0.15	-1.30
Income
Income Before Tax	12.40	8.51	6.90	2.50	-0.26	4.15	1.56	1.89	2.32
Income Tax Expense	2.17	1.62	0.94	-0.79	-0.37	0.82	0.32	-0.05	-0.67
Net Income	10.23	6.89	5.96	3.29	0.11	3.39	1.34	2.05	3.13
Net Income - Continuous Operations	10.23	6.89	5.96	3.29	0.11	3.39	1.34	2.05	3.13
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	19.83	14.86	13.58	9.09	4.59	8.04	5.24	5.34	5.64
EBIT	14.02	10.00	8.19	3.83	1.06	0.00	0.00	0.00	0.00
Depreciation & Amortization	5.73	4.96	4.58	5.25	4.02	3.07	2.80	2.64	2.56
Earnings Per Share
Basic EPS	7.00	4.00	2.00	2.00	-	3.00	1.00	2.00	2.00
Diluted EPS	7.00	4.00	2.00	2.00	-	3.00	1.00	2.00	2.00
Basic Shares Outstanding	1.55	1.55	3.10	1.55	1.42	1.31	1.30	1.27	1.27
Diluted Shares Outstanding	1.56	1.56	3.12	1.56	1.43	1.31	1.30	1.27	1.27